Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Simple exercise combo may sharpen mind and body in seniors with memory concerns

NCT ID NCT07278141

Symptom relief Sponsor: Universidad Santo Tomas, Chile Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will test whether adding dual-task activities (like walking while talking) to resistance training improves physical fitness, eye movements, and thinking skills in older adults with mild cognitive impairment. Sixty-six participants will be assigned to resistance training alone, resistance plus dual tasks, or standard care for 8 weeks. Researchers will measure changes in balance, grip strength, memory, and attention before and after the program.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
resistance exercise training combined with dual-task activities
What this could lead to
If successful, this could point toward a simple, drug-free way to help older adults with mild cognitive impairment maintain physical function and thinking skills.
What could go wrong
This is a small, early-stage study with only 66 participants, so results may not apply to everyone. The intervention is non-invasive, but improvements may be modest or not last long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 66 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jan 2026

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 to 90 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Men and women aged 60 years or older * Score between 10 and 25 points on the Montreal Cognitive Assessment (MoCA) scale * Provide informed consent Exclusion Criteria: * Visual or auditory disability that impedes communication * Previous diagnosis of dementia * Wheelchair use * Epilepsy * Progressive or terminal illness * Depression * History of alcoholism * Musculoskeletal or cardiovascular contraindications for strength exercises * Color blindness * Dyslexia * Severe mental or cognitive problems supported by medical reports

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Executive function (cognition) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Executive function (cognition) Physical function Saccadic eye movements

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites in 2 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Arica- Chile y Valencia -España

    Arica, Arica y Parinacota Region, 1000000, Chile

  • Valencia-Spain

    Valencia, Valencia, 46001, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.